1.15  0.01 (0.88%)		01-09 16:00
Open: 1.18 High: 1.2599 Volume: 26,120		Pre. Close: 1.14 Low: 1.14 Market Cap: 55(M)

Short term
Mid term
Targets	6-month :	2.18	1-year :	2.73
Resists	First :	1.87	Second :	2.33
Pivot price	1.38
Supports	First :	1.11	Second :	0.92
MAs	MA(5) :	1.14	MA(20) :	1.52
	MA(100) :	3.87	MA(250) :	5.34
MACD	MACD :	-0.3	Signal :	-0.3
%K %D	K(14,3) :	4	D(3) :	3.6
RSI	RSI(14): 20.3
52-week	High :	14.3	Low :	1.11

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ZYBT ] has closed above bottom band by 30.4%. Bollinger Bands are 61.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 60 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.26 - 1.27	1.27 - 1.27
Low:	1.12 - 1.12	1.12 - 1.13
Close:	1.14 - 1.15	1.15 - 1.16

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Mon, 29 Dec 2025
Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Large Decline in Short Interest - Defense World

Tue, 28 Oct 2025
Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) 26% Share Price Surge Not Quite Adding Up - simplywall.st

Sat, 27 Sep 2025
Risks Still Elevated At These Prices As Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Shares Dive 79% - 富途牛牛

Sun, 14 Sep 2025
Is Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 3.8% Concerning? - Yahoo Finance

Fri, 23 May 2025
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewswire

Mon, 07 Apr 2025
A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	47 (M)
Shares Float	4 (M)
Held by Insiders	91.1 (%)
Held by Institutions	0.3 (%)
Shares Short	31 (K)
Shares Short P.Month	82 (K)

EPS	-0.06
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.89
Profit Margin	-12.7 %
Operating Margin	-46.4 %
Return on Assets (ttm)	-3.5 %
Return on Equity (ttm)	-6.4 %
Qtrly Rev. Growth	-34.5 %
Gross Profit (p.s.)	1.21
Sales Per Share	3.24
EBITDA (p.s.)	-0.05
Qtrly Earnings Growth	0 %
Operating Cash Flow	12 (M)
Levered Free Cash Flow	24 (M)

PE Ratio	-19.17
PEG Ratio	0
Price to Book value	1.27
Price to Sales	0.35
Price to Cash Flow	4.39

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.